SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $65.17M | $62.37M | $47.56M | $40.45M | $28.40M | $25.36M |
| Cost of Revenue | $21.24M | $19.46M | $16.31M | $15.23M | $10.71M | $7.53M |
| Gross Profit | $43.94M | $42.91M | $31.25M | $25.22M | $17.69M | $17.83M |
| Gross Margin | 67.42% | 68.80% | 65.71% | 62.35% | 62.29% | 70.30% |
| Operating Expenses | $110.50M | $117.74M | $119.08M | $96.71M | $55.08M | $50.12M |
| Operating Income | $-66.57M | $-74.83M | $-87.82M | $-71.49M | $-37.39M | $-32.29M |
| Operating Margin | -102.14% | -119.97% | -184.66% | -176.73% | -131.64% | -127.30% |
| Net Income | $-62.49M | $-78.98M | $-87.45M | $-73.67M | $-39.34M | $-33.79M |
| Net Margin | -95.89% | -126.63% | -183.87% | -182.14% | -138.52% | -133.23% |
| EPS (Basic) | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.82 | $-0.53 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A |